I now have comprehensive information to provide a thorough answer on the principles of circulating blood volume replacement. Let me synthesize this.
Principles of Circulating Blood Volume Replacement
1. Normal Blood Volume (Reference Values)
Understanding normal volumes is the starting point for any replacement strategy:
| Population | Estimated Blood Volume |
|---|
| Adult male | ~70 mL/kg |
| Adult female | ~65 mL/kg |
| Full-term neonate | ~80-90 mL/kg |
| Preterm/VLBW neonate | ~100 mL/kg |
| Infant/child | ~80 mL/kg |
The total circulating volume in a 70 kg adult is approximately 4.9-5 litres.
2. Goals of Volume Replacement
The primary objective of resuscitation following hemorrhage or volume loss is to restore effective circulating blood volume to maintain adequate tissue perfusion and oxygenation. The secondary goals are:
-
Maintain oxygen-carrying capacity (hemoglobin/hematocrit)
-
Restore coagulation factor activity
-
Correct the metabolic consequences of shock (acidosis, hypothermia)
-
Avoid the complications of over-resuscitation (dilutional coagulopathy, tissue oedema, abdominal compartment syndrome)
-
Mulholland and Greenfield's Surgery, 7e
3. Classification of Volume Loss (Hemorrhagic Shock)
Guides the type and volume of replacement:
| Class | Blood Loss | Signs | Replacement |
|---|
| I | Up to 15% (~750 mL) | Minimal | Crystalloid only |
| II | 15-30% (750-1500 mL) | Tachycardia, anxiety | Crystalloid ± blood |
| III | 30-40% (1500-2000 mL) | Hypotension, confusion | Blood products + crystalloid |
| IV | >40% (>2000 mL) | Life-threatening | Massive transfusion protocol |
4. Types of Replacement Fluids
A. Crystalloids
Isotonic crystalloids (Ringer's lactate / Hartmann's solution, normal saline) are the first-line agents. Hartmann's solution most closely replicates plasma osmolality and is preferred. Key points:
- Distribute across the entire extracellular space (interstitial + intravascular), so only ~25% remains intravascular
- Require 3-4x the volume lost to restore intravascular volume
- Large volumes cause dilutional coagulopathy, acidosis, and tissue oedema
- Preferred for initial resuscitation: 20 mL/kg boluses in children; 1-2 L boluses in adults
B. Colloids
- Larger molecules that remain in the intravascular compartment longer (better plasma volume expansion per mL given)
- Crystalloid requires 8-fold greater volumes than colloid to achieve equivalent plasma expansion
- Examples: albumin, hydroxyethyl starch, gelatin solutions
- Meta-analyses show no clear mortality benefit over crystalloids in most settings; colloids remain more expensive
- Use is context-dependent (perioperative, burns after 24 h)
C. Hypertonic Saline (3% or 7.5%)
-
Draws water from intracellular and interstitial compartments into the vascular space
-
Achieves volume resuscitation with low infused volumes - particularly useful in austere/military settings and for concurrent traumatic brain injury
-
Can cause hyperchloremic acidosis
-
Given as a one-time bolus (5% hypertonic saline) in the early phase of resuscitation
-
Benefit over isotonic saline not confirmed by large RCTs for general trauma
-
Mulholland and Greenfield's Surgery, 7e
D. Blood Products
- Packed Red Blood Cells (pRBCs): Restore oxygen-carrying capacity. Transfused in 10 mL/kg increments in children (~500 mL equivalent in a 70 kg adult). Formula for PRBC volume needed:
(Target Hct - Current Hct) x Weight (kg) x 80 / 65
-
Fresh Frozen Plasma (FFP): Replaces coagulation factors. Dosed at 10-20 mL/kg. Used when coagulopathy is present or when >30 mL/kg blood products transfused in children.
-
Platelets: Dosed at 1 unit/5 kg in children. Required if >30 mL/kg transfused or platelet count falls below threshold.
-
Cryoprecipitate: Rich in fibrinogen and factor VIII; used as an adjunct in trauma-induced coagulopathy.
-
Schwartz's Principles of Surgery, 11e
5. Modern Strategies
A. Damage Control Resuscitation (DCR)
A major paradigm shift from aggressive crystalloid loading:
-
Permissive hypotension: Target systolic BP ~90 mmHg (MAP ~60 mmHg) before definitive hemorrhage control. This prevents "popping the clot" and worsening hemorrhage. Avoid in TBI, blunt trauma, elderly, and patients with cardiac/carotid disease.
-
Early blood product administration: Minimize crystalloid, prioritize RBCs, FFP, and platelets
-
1:1:1 ratio (RBC:FFP:Platelets): Reconstitutes "whole blood," reduces dilutional coagulopathy. Derived from military data showing improved survival. Adopted in civilian massive transfusion protocols (MTP).
-
Tranexamic acid (TXA): Antifibrinolytic; effective if given within 3 hours of injury. Reduces risk of death from bleeding. Recommended by CRASH-2 trial and military guidelines (15 mg/kg IV bolus over 20 minutes, then 2 mg/kg/h for 8 hours in children).
-
Avoid the lethal triad: Hypothermia + acidosis + coagulopathy - mutually self-reinforcing and fatal.
-
Mulholland and Greenfield's Surgery, 7e
B. Massive Transfusion Protocol (MTP)
Defined as transfusion of ≥1 circulating blood volume (or ≥10 units RBCs) within 24 hours. Triggered when:
-
40 mL/kg blood products needed in adolescents
-
50 mL/kg in children/infants
Protocol involves predefined 1:1:1 or 1:1 (pRBC:FFP) ratios. Scoring systems (ABC score, TASH score) help identify patients likely to need MTP at presentation.
- Tietz Textbook of Laboratory Medicine, 7e; Mulholland and Greenfield's Surgery, 7e
C. Goal-Directed Therapy (GDT)
In perioperative or non-hemorrhagic settings:
-
Titrate fluid to measurable endpoints: stroke volume (SV), stroke volume variation (SVV), cardiac output
-
Administer 250 mL boluses of colloid or crystalloid aiming for a 10% rise in SV
-
Continue until SV no longer increases (Starling plateau)
-
Reduces postoperative complications, renal impairment, respiratory failure, and hospital stay
-
Monitors: esophageal Doppler, arterial waveform analysis (FloTrac, LiDCO), echocardiography
-
Miller's Anesthesia, 10e
6. Endpoints of Resuscitation
Do not resuscitate to arbitrary blood pressure targets. Assess adequacy by:
| Endpoint | Target |
|---|
| Systolic BP | >90 mmHg (permissive) or >100 mmHg (controlled) |
| Mean arterial pressure (MAP) | ≥60 mmHg |
| Urine output | 0.5-1 mL/kg/h (adults); 1 mL/kg/h (children) |
| Lactate | Normalizing trend (serial measurements) |
| ScvO2 | >70% |
| Base deficit | Improving toward 0 |
| Hemoglobin trigger | 70 g/L (stable critically ill); higher if cardiac/respiratory compromise |
7. Special Considerations
- Pediatrics: Blood volume ~80 mL/kg; start with 20 mL/kg crystalloid boluses x2, then 10 mL/kg pRBC if no improvement
- Ruptured AAA: Permissive hypotension (SBP 70-90 mmHg) to operating room; PRBC:FFP ratio <2:1
- Burns: Parkland formula (4 mL/kg x %TBSA burned); half in first 8 hours, half over next 16 hours; crystalloid is first choice
- TBI + hemorrhage: Avoid permissive hypotension; maintain MAP ≥80 mmHg to preserve cerebral perfusion pressure
Key takeaway: Modern blood volume replacement has moved from "flood with crystalloid" to a precision strategy - early hemorrhage control, permissive hypotension, blood product-based resuscitation in 1:1:1 ratios, antifibrinolytics within 3 hours, and goal-directed monitoring to avoid both under- and over-resuscitation.